Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more
Eyebright Medical Technology Beijing Co Ltd (688050) - Total Liabilities
Latest total liabilities as of September 2025: CN¥894.96 Million CNY
Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has total liabilities worth CN¥894.96 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Eyebright Medical Technology Beijing Co Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Eyebright Medical Technology Beijing Co Ltd Competitors by Total Liabilities
The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grenergy Renovables S.A
MC:GRE
|
Spain | €1.75 Billion |
|
Hainan Development Holdings Nanhai Co Ltd
SHE:002163
|
China | CN¥5.56 Billion |
|
Integrated Cannabis Company Inc
PINK:CRPGF
|
USA | $174.81 Billion |
|
Koh Young Technology Inc
KQ:098460
|
Korea | ₩62.23 Billion |
|
Perpetual Ltd
AU:PPT
|
Australia | AU$1.77 Billion |
|
Coastal Financial Corp
NASDAQ:CCB
|
USA | $4.25 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Eyebright Medical Technology Beijing Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eyebright Medical Technology Beijing Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eyebright Medical Technology Beijing Co Ltd (2016–2024)
The table below shows the annual total liabilities of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥862.71 Million | +22.22% |
| 2023-12-31 | CN¥705.85 Million | +117.65% |
| 2022-12-31 | CN¥324.30 Million | +5.48% |
| 2021-12-31 | CN¥307.46 Million | +238.26% |
| 2020-12-31 | CN¥90.89 Million | +137.60% |
| 2019-12-31 | CN¥38.26 Million | +17.40% |
| 2018-12-31 | CN¥32.59 Million | -58.02% |
| 2017-12-31 | CN¥77.62 Million | +69.20% |
| 2016-12-31 | CN¥45.88 Million | -- |